-
1
-
-
0031052368
-
Intranasal booster vaccination against diphtheria and tetanus in man
-
Aggerbeck, H., S. Gizurarson, J. Wantzin, and I. Heron. 1997. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 15:307-316.
-
(1997)
Vaccine
, vol.15
, pp. 307-316
-
-
Aggerbeck, H.1
Gizurarson, S.2
Wantzin, J.3
Heron, I.4
-
3
-
-
0026748957
-
Serious respiratory tract disease caused by Respiratory Syncytial Virus: Prospects for improved therapy and effective immunization
-
Chanock, R.M., R.H. Parrott, M. Connors, P.L. Collins, and B.R. Murphy. 1992. Serious respiratory tract disease caused by Respiratory Syncytial Virus: Prospects for improved therapy and effective immunization. Pediatrics 90:137-143.
-
(1992)
Pediatrics
, vol.90
, pp. 137-143
-
-
Chanock, R.M.1
Parrott, R.H.2
Connors, M.3
Collins, P.L.4
Murphy, B.R.5
-
5
-
-
0029742729
-
Intranasal vaccination against Influenza using pharmaceutical excipients as immunological adjuvants
-
Gizurarson, S., H. Aggerbeck. S.G. Arnadottir, C.H. Mordhorst, and I. Heron. 1996. Intranasal vaccination against Influenza using pharmaceutical excipients as immunological adjuvants. Vaccine Res. 5:69-75.
-
(1996)
Vaccine Res.
, vol.5
, pp. 69-75
-
-
Gizurarson, S.1
Aggerbeck, H.2
Arnadottir, S.G.3
Mordhorst, C.H.4
Heron, I.5
-
6
-
-
0030809419
-
Intranasal vaccination against diphtheria and tetanus in human subjects
-
Gizurarson, S., H. Aggerbeck, F.K. Gudbrandsson, H. Valdimarsson, and I. Heron. 1997. Intranasal vaccination against diphtheria and tetanus in human subjects. Vaccine Res. 6:41-47.
-
(1997)
Vaccine Res.
, vol.6
, pp. 41-47
-
-
Gizurarson, S.1
Aggerbeck, H.2
Gudbrandsson, F.K.3
Valdimarsson, H.4
Heron, I.5
-
7
-
-
0029041721
-
Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics
-
Gizurarson, S., V.M. Jonsdottir, and I. Heron. 1995. Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine 13:617-621.
-
(1995)
Vaccine
, vol.13
, pp. 617-621
-
-
Gizurarson, S.1
Jonsdottir, V.M.2
Heron, I.3
-
8
-
-
0028089006
-
The pulmonary im-mune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus
-
Hancock, G.E., D.J. Hahn, D.J. Speelman, S.W. Hildreth, S. Pillai, and K. McQueen. 1994. The pulmonary im-mune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus. Vaccine 12:267-274.
-
(1994)
Vaccine
, vol.12
, pp. 267-274
-
-
Hancock, G.E.1
Hahn, D.J.2
Speelman, D.J.3
Hildreth, S.W.4
Pillai, S.5
McQueen, K.6
-
9
-
-
0028902386
-
Formulation of the purified fusion protein or respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection
-
Hancock, G.E., D.J. Speelman, P.J. Frenchick, M.M. Mineo-Kuhn, R.B. Baggs, and D.J. Hahn. 1995. Formulation of the purified fusion protein or respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine 13:391-400.
-
(1995)
Vaccine
, vol.13
, pp. 391-400
-
-
Hancock, G.E.1
Speelman, D.J.2
Frenchick, P.J.3
Mineo-Kuhn, M.M.4
Baggs, R.B.5
Hahn, D.J.6
-
10
-
-
0031925039
-
Priming with secreted glycoprotein G of Respiratory Syncytial Virus (RSV) augments Interleukin-5 production and tissue eosinophilia after RSV challenge
-
Johnson, T.R., J.E. Johnson, S.R. Roberts, G.W. Wertz, R.A. Parker, and B.S. Graham. 1998. Priming with secreted glycoprotein G of Respiratory Syncytial Virus (RSV) augments Interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72:2871-2880.
-
(1998)
J. Virol.
, vol.72
, pp. 2871-2880
-
-
Johnson, T.R.1
Johnson, J.E.2
Roberts, S.R.3
Wertz, G.W.4
Parker, R.A.5
Graham, B.S.6
-
11
-
-
0014495251
-
Respiratory Syncytial Virus disease in infants despite prior administration of antigenic inactivated vaccine
-
Kim, H.W., J.G. Canchola, C.D. Brandt, R.M. Chanock, K. Jensen, and R.H. Parrott. 1969. Respiratory Syncytial Virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
-
(1969)
Am. J. Epidemiol.
, vol.89
, pp. 422-434
-
-
Kim, H.W.1
Canchola, J.G.2
Brandt, C.D.3
Chanock, R.M.4
Jensen, K.5
Parrott, R.H.6
-
12
-
-
0030839517
-
N-trimethyl chitosan chloride as a potential absorption agent enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2)
-
Kot'e, A.F., H.L. Luessen, B.J. de Leeuw, B.G. de Boer, J.C. Verhoef, and H.E. Junginger. 1997. N-trimethyl chitosan chloride as a potential absorption agent enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm. Res. 14:1197-1202.
-
(1997)
Pharm. Res.
, vol.14
, pp. 1197-1202
-
-
Kot'e, A.F.1
Luessen, H.L.2
De Leeuw, B.J.3
De Boer, B.G.4
Verhoef, J.C.5
Junginger, H.E.6
-
13
-
-
0028175128
-
Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit
-
Oien, N.L., R.J. Brideau, E.E. Walsh, and M.W. Wathen. 1994. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 12:731-735.
-
(1994)
Vaccine
, vol.12
, pp. 731-735
-
-
Oien, N.L.1
Brideau, R.J.2
Walsh, E.E.3
Wathen, M.W.4
-
14
-
-
0031882271
-
Respiratory Syncytial Virus affects pulmonary function in BALB/c mice
-
Van Schaik, S.M., G. Enhorning, I. Vargas, and R.C. Welliver. 1998. Respiratory Syncytial Virus affects pulmonary function in BALB/c mice. J. Infect. Dis. 177:269-276.
-
(1998)
J. Infect. Dis.
, vol.177
, pp. 269-276
-
-
Van Schaik, S.M.1
Enhorning, G.2
Vargas, I.3
Welliver, R.C.4
-
15
-
-
0030821968
-
Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo
-
Vermehren, C., P.B. Johansen, and H.S. Hansen. 1997. Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo. Drug Metab. Dispos. 25:1083-1088.
-
(1997)
Drug Metab. Dispos.
, vol.25
, pp. 1083-1088
-
-
Vermehren, C.1
Johansen, P.B.2
Hansen, H.S.3
-
16
-
-
0027257098
-
Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice
-
Walsh, E.E. 1993. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice. Vaccine 11:1135-1138.
-
(1993)
Vaccine
, vol.11
, pp. 1135-1138
-
-
Walsh, E.E.1
|